Today: 19 January 2026
Subscribe
Browse Category

Market News News 20 October 2025 - 24 October 2025

Broadcom’s AI Windfall: Inside AVGO’s Trillion-Dollar Surge, $10B Chip Deal & 2025 Outlook

Broadcom (AVGO) Stock Skyrockets on $10B OpenAI AI Chip Deal — Are $450 Targets Next?

Broadcom’s stock has soared in recent days as the chipmaker emerges as a central player in the booming AI industry. On Friday, Oct. 24, the shares were trading in the mid-$350s – about double their level a year earlier – and were up around 3–4% on the day Investing. The recent jump follows a series of bullish developments for AVGO.…
24 October 2025
····
WGRX Stock Soars on Blockchain Deal as Wellgistics Health Eyes Pharma Disruption

WGRX Stock Soars on Blockchain Deal as Wellgistics Health Eyes Pharma Disruption

Stock Price Rally Powered by Tech Tie-Up Wellgistics Health’s stock price is on a tear after embracing blockchain technology. The tiny healthcare logistics firm saw its shares surge from about $0.40 to the mid-$0.70s overnight on news of a cutting-edge partnership. In after-hours trading late Thursday, WGRX jumped 87.9%, nearly doubling in value Benzinga. The stock is now trading around…
24 October 2025
···
Incredible Rally: Bitfarms (BITF) Stock Jumps 148% YTD Amid Crypto Boom & AI Pivot

Bitfarms (BITF) Stock Rockets: Bitcoin at $125K & $500M AI Data Deal Fuel Rally

The bottom line: Bitfarms is riding a double tailwind of an explosive Bitcoin rally and its own strategic shift into AI data centers. Its stock is highly volatile (beta ~4–5) and swings with crypto prices. After a furious multi-month rally, BITF has paused and retraced from its mid-October highs (reflecting classic overbought conditions ts2.tech). Whether the rally continues hinges on…
23 October 2025
····
Armata (ARMP) Stock Surges 150% After Breakthrough Bacteriophage Trial Results

Armata (ARMP) Stock Surges 150% After Breakthrough Bacteriophage Trial Results

Armata’s stock performance this week has been nothing short of dramatic. Prior to Oct. 22, ARMP had been trading in the low-$3 range (for example, it closed around $3.41 on Oct. 16 Marketbeat). Once the late-breaking IDWeek data was announced, the shares rocketed – briefly hitting an intraday high near $16 (per some quotes) before settling at about $8.87 Finviz…
22 October 2025
···
Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific’s Q3 report blew past expectations. Marlborough, MA-based Boston Scientific (NYSE:BSX) posted reported net income of $755 M ($0.51/share GAAP) and adjusted EPS of $0.75 Timesunion Chartmill, topping the $0.71–$0.72 analysts’ forecast. CEO Mike Mahoney called it “another exceptional quarter of strong performance” Prnewswire, fueled by robust growth across all businesses. Total sales were $5.065 B, up 20.3% from a year…
22 October 2025
····
Shocking Rate Decision in Indonesia Sparks Market Jitters and Forecast Frenzy

Shocking Rate Decision in Indonesia Sparks Market Jitters and Forecast Frenzy

Central Bank Shocks Markets by Holding Rates Steady Indonesia’s central bank sprang a surprise on October 22 by keeping its key interest rate unchanged at 4.75%, defying widespread expectations of a rate cut. This decision – announced at the conclusion of Bank Indonesia’s Board of Governors meeting – caught markets off guard, as most forecasters had penciled in a fourth…
22 October 2025
··
VSee Health (VSEE) Stock Rockets 75% on $10M Hospital Teleradiology Deal – Is This Telehealth’s Next Big Winner?

VSee Health (VSEE) Stock Rockets 75% on $10M Hospital Teleradiology Deal – Is This Telehealth’s Next Big Winner?

VSee’s Game-Changing Teleradiology Deal On Oct. 21, 2025 VSee Health (NASDAQ: VSEE) announced a “landmark” multi-year teleradiology contract with a major Level 1 trauma hospital system Finviz. Under the deal (executed May 7, 2025, services since June), VSee will provide 24/7 remote radiology interpretations across a network of hospitals. The company projects $10 million in gross revenue over two years from…
21 October 2025
··
Yueda Digital (YDKG) Stock Crashes 90% After $28M Crypto Fundraise – Bargain or Bubble?

Yueda Digital (YDKG) Stock Crashes 90% After $28M Crypto Fundraise – Bargain or Bubble?

Yueda Digital (Nasdaq: YDKG) – a small-cap crypto/finance stock – saw its share price tumble in mid-Oct 2025 amid heavy selling. Recent corporate events (including a $28M share sale and CEO change) drove the plunge Stockinvest Finimize. Though YDKG touts “explosive” crypto-driven growth, the stock is near its lows and extremely volatile. Stock Performance and Trend YDKG has collapsed in…
21 October 2025
····
Coca-Cola Crushes Q3 Forecasts as Soda Sales Stay Hot – Stock Jumps

Coca-Cola Crushes Q3 Forecasts as Soda Sales Stay Hot – Stock Jumps

Strong Q3 Performance Beats Estimates Coca-Cola’s (NYSE: KO) Q3 2025 report blew past Wall Street’s forecasts. The beverage giant logged $12.5 billion in revenue, up 5% from last year (organic sales +6%) Stocktitan. This exceeded the ~$12.39 billion consensus Reuters. Volume was flat to slightly positive (+1%), but robust price/mix (+6%) drove growth. As a result, EPS of $0.86 surged 30% year-over-year…
21 October 2025
···
Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa (AA) Stock Poised for Breakout? Gallium Project, Tariff Relief & $40 Target Stun Investors

Alcoa’s stock story is a mix of bullish projects and market risks. The recent government-backed gallium plant (critical mineral for tech and defense) is a major positive, potentially diversifying Alcoa’s business beyond aluminium. Yet the industry is grappling with high US tariffs and costs. Below we break down these developments and what analysts are saying. Government support and the new…
21 October 2025
··
DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

DocGo (NASDAQ: DCGO) Stock Rockets After Virtual Care Acquisition – Can the Rally Last?

Stock Surges on SteadyMD Acquisition DocGo’s shares jumped more than 34% in after-hours trading on Oct. 20, 2025, after the company announced it would acquire SteadyMD, a virtual care platform. According to an Investing.com report, DocGo stock “surged 34.6% in after-hours trading Monday following the company’s announcement that it has acquired virtual care platform SteadyMD” Investing. The acquisition was disclosed…
21 October 2025
····
AI Drug Discovery Darling? Recursion Pharma (RXRX) Stock’s Wild Ride in 2025

Recursion Pharma Stock Soars 16% on AI Buzz and Big Pharma Deals – Can RXRX Keep Climbing?

Stock Soars on Oct 20 Amid Wild October Trading Recursion’s stock is on a rollercoaster ride this month. Early on October 20, RXRX surged ~16–18%, hitting intraday highs near $6.8 Benzinga. The rally comes after shares slid 7.9% on Friday to $5.86 Stockinvest, as traders took profits following a mid-October run-up. Broader market tailwinds helped – the Nasdaq Composite was…
20 October 2025
····
1 … 58 59 60 61 62 63

Stock Market Today

  • Abbott Laboratories (ABT.SW) Trades at CHF100 Ahead of Jan 22 Earnings
    January 19, 2026, 9:27 AM EST. ABT.SW stock trades at CHF100.00 on the SIX market on Jan 19, 2026, ahead of Abbott Laboratories' earnings report due Jan 22. The shares carry a price-to-earnings (PE) ratio of 15.82, below the healthcare sector average of 33.73, signaling potential undervaluation. Key catalysts include diagnostic volume and medical devices sales, which investors will watch for guidance. Forecasts project a 10.78% quarterly upside but an 8.31% yearly downside, reflecting mixed expectations amid stable cash flow and modest growth. Meyka AI assigns a BUY rating with a B+ grade, noting technical indicators near the 50-day moving average and light volume. Risks include normalization of diagnostic demand and regulatory pressures; opportunities hinge on growth acceleration. Earnings-driven volatility expected on release day.
Go toTop